Release Date: 19/10/11 10:03 Summary: Letter to S/holders -Renounceable Pro Rata Entitlement Offer Price Sensitive: No Download Document 147.77KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status